Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|September 28, 2002
Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortalityWafaie W Fawzi, Gernard I Msamanga, David Hunter, et al.
Antiviral Chemistry & Chemotherapy|May 14, 2005
HIV-1 subtype C drug-resistance background among ARV-naive adults in BotswanaHermann Bussmann, Vladimir Novitsky, William Wester, et al.
AIDS Patient Care and Stds|January 5, 2017
High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral TherapyRebecca Marie Zash, Sajini Souda, Jean Leidner, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2014
HIV-1 drug mutations in children from northern TanzaniaElichilia R Shao, Emmanuel G Kifaro, Innocent B Chilumba, et al.
Plos One|March 25, 2014
Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidityElizabeth S Russell, Terence Mohammed, Laura Smeaton, et al.
Sexually Transmitted Diseases|March 5, 2003
Herpes simplex virus type 2 infection among bar and hotel workers in northern Tanzania: prevalence and risk factorsSaidi H Kapiga, Noel E Sam, John F Shao, et al.
AIDS (London, England)|December 22, 2009
Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in BotswanaC William Wester, Ann Muir Thomas, Hermann Bussmann, et al.
Journal of the International AIDS Society|October 27, 2009
Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimensFlorence Doualla-Bell, Tendani Gaolathe, Ava Avalos, et al.
Journal of the Pediatric Infectious Diseases Society|April 25, 2018
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in BotswanaRebecca Zash, Kathryn Rough, Denise L Jacobson, et al.
The Journal of Infectious Diseases|August 10, 2005
Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milkRoger L Shapiro, Thumbi Ndung'u, Shahin Lockman, et al.
Pageof 16